NAY PYI TAW - Myanmar, China and Bangladesh on Friday reached an agreement on electric power trade at a trilateral ministerial meeting in Nay Pyi Taw.Matters relating to starting trilateral cross-border power trading and its implementation mechanism were discussed at the plenary meeting, aimed at enhancing cooperation on electric power trading through promoting the interconnection of power grid and infrastructure development among the three countries.The trilateral agreement to trade electric power among neighboring countries could help with the improvement of energy security, sharing of electricity resources, infrastructure development, capacity development of officials and job opportunity as well as strengthening of long term friendship and fulfilling of the basic requirements of electricity supply to support the economic development for each country, a statement of Myanmar's Electricity and Energy Ministry said.Present at the meeting were Myanmar's Union Minister U Win Khaing for Electricity and Energy, vice administrator of National Energy Administration of China Li Fanrong, advisor to Prime Minister for Power, Energy and Mineral Resources Affairs of Bangladesh Dr. Tawfiq-e-Elahi Chowdhury BB. colored rubber bands for braceletscheap silicone wristbands canadamiscarriage awareness silicone braceletsdebossed-wristbandpaw print silicone braceletsembossed-wristbandblank wristbanddual-layer-wristbandplain black silicone wristbandscamo silicone wristbands
Latest Tests show Meheco's human immunoglobulin HIV negative A screenshot on its official website shows the human immunoglobulin for intravenous injection manufactured by China Meheco Xinxing Pharma Co in Shanghai. BEIJING/SHANGHAI - China's health authorities Wednesday launched an investigation into a batch of human immunoglobulin for intravenous injection, which were reported to be HIV antibody positive. The drugs, carrying the batch number of 20180610Z, were manufactured by China Meheco Xinxing Pharma Co in Shanghai. Shanghai's drug watchdog has ordered the company to halt production and initiate emergency recall of its products. The National Health Commission said it has informed the National Medical Products Administration to demand medical institutions nationwide to stop using and seal products of the said batch number. The commission said the risk of HIV infection is very low for those who have been injected the product, based on related literatures, manufacturing technique and the pH value of the product. A follow-up monitoring plan has been made for these people, it said. The commission has sent a working team to Shanghai to supervise and guide related work. A group of experts sent by the National Medical Products Administration has arrived in Shanghai for site inspection at the company. All the related production and inspection records have been sealed.
